[1] Ruby HA, Sayed RH, Khattab MA, et al. Fenofibrate ameliorates nitroglycerin-induced migraine in rats: role of CGRP/p-CREB/P2X3 and NGF/PKC/ASIC3 signaling pathways[J]. Eur J Pharmacol, 2024, 976: 176667. doi:10.1016/j.ejphar.2024.176667. [2] Rushendran R, Singh A, Ankul Singh S, et al. A role of NLRP3 and MMP9 in migraine progression: a systematic review of translational study[J]. Front Neurol, 2024, 15: 1307319. doi:10.3389/fneur.2024.1307319. [3] Nie L, Ma D, Quinn JP, et al. Src family kinases activity is required for transmitting purinergic P2X7 receptor signaling in cortical spreading depression and neuroinflammation[J]. J Headache Pain, 2021, 22: 146. doi:10.1186/s10194-021-01359-8. [4] Guo J, Wang C, Niu X, et al. Effects of resveratrol in the signaling of neuropathic pain involving P2X3 in the dorsal root ganglion of rats[J]. Acta Neurol Belg, 2021, 121: 365-372. [5] Wang Y, Wang RR, Sun W, et al. Analgesic effect of dl-THP on inflammatory pain mediated by suppressing spinal TRPV1 and P2X3 receptors in rats[J]. Front Biosci (Landmark Ed), 2021, 26: 1-10. [6] Xia LP, Luo H, Ma Q, et al. GPR151 in nociceptors modulates neuropathic pain via regulating P2X3 function and microglial activation[J]. Brain, 2021, 144: 3405-3420. [7] Aleksovska K, Hershey AD, Deen M, et al. Efficacy and safety of monoclonal antibodies targeting CGRP in migraine prevention. GRADE tables elaborated by the ad hoc working group of the International Headache Society[J]. Cephalalgia, 2023, 43: doi:10.1177/03331024231206162. [8] Yegutkin GG, Guerrero-Toro C, Kilinc E, et al. Nucleo-tide homeostasis and purinergic nociceptive signaling in rat meninges in migraine-like conditions[J]. Purinergic Signal, 2016, 12: 561-574. [9] Suleimanova A, Talanov M, van den Maagdenberg A, et al. Deciphering in silico the role of mutated Na (V) 1.1 sodium channels in enhancing trigeminal nociception in familial hemiplegic migraine type 3[J]. Front Cell Neurosci, 2021, 15: 644047. doi:10.3389/fncel.2021.644047. [10] McDonough KE, Hammond R, Wang J, et al. Spinal GABAergic disinhibition allows microglial activation mediating the development of nociplastic pain in male mice[J]. Brain Behav Immun, 2023, 107: 215-224. [11] Gilabert D, Duveau A, Carracedo S, et al. Microglial P2X4 receptors are essential for spinal neurons hyperexcitability and tactile allodynia in male and female neuropathic mice[J]. iScience, 2023, 26: 108110. doi:10.1016/j.isci.2023.108110. [12] Long T, He W, Pan Q, et al. Microglia P2X4R-BDNF signalling contributes to central sensitization in a recurrent nitroglycerin-induced chronic migraine model[J]. J Headache Pain, 2020, 21: 4. doi:10.1186/s10194-019-1070-4. [13] Zhou M, Pang F, Liao D, et al. Electroacupuncture improves allodynia and central sensitization via modulation of microglial activation associated P2X4R and inflammation in a rat model of migraine[J]. Mol Pain, 2024, 20: 17448069241258113. doi:10.1177/17448069241258113. [14] Yu J, Wong S, Lin Z, et al. High-frequency spinal stimulation suppresses microglial Kaiso-P2X7 receptor axis-induced inflammation to alleviate neuropathic pain in rats[J]. Ann Neurol, 2024, 95: 966-983. [15] Yang R, Shi L, Si H, et al. Gallic acid improves comorbid chronic pain and depression behaviors by inhibiting P2X7 receptor-mediated ferroptosis in the spinal cord of rats[J]. ACS Chem Neurosci, 2023, 14: 667-676. [16] Zhou Y, Xu Y, Yang J, et al. Spinal cannabinoid receptor 2 activation alleviates neuropathic pain by regulating microglia and suppressing P2X7 receptor[J]. Front Mol Neurosci, 2023, 16: 1061220. doi:10.3389/fnmol.2023.1061220. [17] Yamashita T, Kamikaseda S, Tanaka A, et al. New inhibitory effects of cilnidipine on microglial P2X7 receptors and IL-1β release: an involvement in its alleviating effect on neuropathic pain[J]. Cells, 2021, 10:doi:10.3390/cells10020434. [18] Gui X, Wang H, Wu L, et al. Botulinum toxin type A promotes microglial M2 polarization and suppresses chronic constriction injury-induced neuropathic pain through the P2X7 receptor[J]. Cell Biosci, 2020, 10: 45. doi:10.1186/s13578-020-00405-3. [19] Huang ACW, Shih HC, Shyu BC. The P2X7 hypothesis of central post-stroke pain[J]. Int J Mol Sci, 2024, 25:doi:10.3390/ijms25126577. [20] Zhao J, Harrison S, Levy D. Meningeal P2X7 signaling mediates migraine-related intracranial mechanical hypersensitivity[J]. J Neurosci, 2023, 43: 5975-5985. [21] Uzay B, Donmez-Demir B, Ozcan SY, et al. The effect of P2X7 antagonism on subcortical spread of optogenetically-triggered cortical spreading depression and neuroinflammation[J]. J Headache Pain, 2024, 25: 120. doi:10.1186/s10194-024-01807-1. [22] Wang Y, Shan Z, Zhang L, et al. P2X7R/NLRP3 signaling pathway-mediated pyroptosis and neuroinflammation contributed to cognitive impairment in a mouse model of migraine[J]. J Headache Pain, 2022, 23: 75. doi:10.1186/s10194-022-01442-8. [23] Jiang L, Zhang Y, Jing F, et al. P2X7R-mediated autophagic impairment contributes to central sensitization in a chronic migraine model with recurrent nitroglycerin stimulation in mice[J]. J Neuroinflammation, 2021, 18: 5. doi:10.1186/s12974-020-02056-0. |